These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2000644)

  • 61. Oxidative polymorphism of debrisoquine is not related to the risk of Alzheimer's disease.
    Benítez J; Barquero MS; Coria F; Molina JA; Jiménez-Jiménez FJ; Ladero JM
    J Neurol Sci; 1993 Jul; 117(1-2):8-11. PubMed ID: 8410072
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sparteine and mephenytoin oxidation: genetic polymorphisms in east and west Greenland.
    Clasen K; Madsen L; Brøsen K; Albøge K; Misfeldt S; Gram LF
    Clin Pharmacol Ther; 1991 Jun; 49(6):624-31. PubMed ID: 2060251
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quinidine kinetics after a single oral dose in relation to the sparteine oxidation polymorphism in man.
    Brøsen K; Davidsen F; Gram LF
    Br J Clin Pharmacol; 1990 Feb; 29(2):248-53. PubMed ID: 2306418
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The genetic polymorphism of sparteine metabolism.
    Eichelbaum M; Reetz KP; Schmidt EK; Zekorn C
    Xenobiotica; 1986 May; 16(5):465-81. PubMed ID: 3739368
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetics of drug transformation.
    Kalow W
    Clin Biochem; 1986 Apr; 19(2):76-82. PubMed ID: 3518992
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Polymerase chain reaction and its potential as a pharmacokinetic tool.
    Heim MH
    Clin Pharmacokinet; 1992 Nov; 23(5):321-7. PubMed ID: 1362142
    [No Abstract]   [Full Text] [Related]  

  • 67. Genetically determined adverse drug reactions involving metabolism.
    Lennard MS
    Drug Saf; 1993 Jul; 9(1):60-77. PubMed ID: 8347292
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sparteine oxidation polymorphism in Denmark.
    Brøsen K; Otton SV; Gram LF
    Acta Pharmacol Toxicol (Copenh); 1985 Nov; 57(5):357-60. PubMed ID: 4090995
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10.
    Meehan RR; Gosden JR; Rout D; Hastie ND; Friedberg T; Adesnik M; Buckland R; van Heyningen V; Fletcher J; Spurr NK
    Am J Hum Genet; 1988 Jan; 42(1):26-37. PubMed ID: 2827463
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interpatient variability: genetic predisposition and other genetic factors.
    West WL; Knight EM; Pradhan S; Hinds TS
    J Clin Pharmacol; 1997 Jul; 37(7):635-48. PubMed ID: 9243358
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genetically variable metabolism of antidepressants and neuroleptic drugs in man.
    Dahl ML; Bertilsson L
    Pharmacogenetics; 1993 Apr; 3(2):61-70. PubMed ID: 8100166
    [No Abstract]   [Full Text] [Related]  

  • 72. Polymorphic sparteine metabolism and amyotrophic lateral sclerosis.
    Kaneko K; Atsumi T; Miyatake T
    J Neurol; 1989 Dec; 236(8):452-5. PubMed ID: 2614489
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Benzbromarone biotransformation is not related to polymorphic oxidation of sparteine.
    Walter-Sack I; Eichelbaum M; de Vries JX; Weber E
    Klin Wochenschr; 1988 Nov; 66(21):1097-8. PubMed ID: 3236759
    [No Abstract]   [Full Text] [Related]  

  • 74. Role of genetic polymorphism in psychopharmacology--an update.
    Brøsen K; Sindrup SH; Skjelbo E; Nielsen KK; Gram LF
    Psychopharmacol Ser; 1993; 10():199-211. PubMed ID: 8361977
    [No Abstract]   [Full Text] [Related]  

  • 75. Chromosomal assignment of human cytochrome P-450 (debrisoquine/sparteine type) to chromosome 22.
    Eichelbaum M; Baur MP; Dengler HJ; Osikowska-Evers BO; Tieves G; Zekorn C; Rittner C
    Br J Clin Pharmacol; 1987 Apr; 23(4):455-8. PubMed ID: 3472585
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cytochrome P-450-dependent hydroxylation in migraine.
    Dahlöf C; Alm C; Bertling I; Barret L
    Cephalalgia; 1992 Jun; 12(3):158-60. PubMed ID: 1623510
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Absence of polymorphism of sparteine oxidation in the South African Venda.
    Sommers DK; Moncrieff J; Avenant JC
    Hum Exp Toxicol; 1991 May; 10(3):175-8. PubMed ID: 1678945
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation.
    Gonzalez FJ; Nebert DW
    Trends Genet; 1990 Jun; 6(6):182-6. PubMed ID: 2196721
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genotypes of cytochrome P450 and clinical response to clomipramine in patients with major depression.
    Bouchez J; Dumur V; Lhermitte M; Goudemand M
    Eur Psychiatry; 1995; 10(8):410-2. PubMed ID: 19698378
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetic variation in the human hepatic cytochrome P-450 system.
    Kalow W
    Eur J Clin Pharmacol; 1987; 31(6):633-41. PubMed ID: 3549324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.